Anesthetic considerations in the patient with valvular heart disease undergoing noncardiac surgery.
Valvular heart disease can be an important finding in patients presenting for noncardiac surgery. Valvular heart disease and resulting comorbidity, such as heart failure or atrial fibrillation, significantly increase the risk for perioperative adverse events. Appropriate preoperative assessment, adequate perioperative monitoring, and early intervention, should hemodynamic disturbances occur, may help prevent adverse events and improve patient outcome. This review article aims to guide the practitioner in the various aspects of anesthetic management in the perioperative care of patients with valvular heart disease. The pharmacological approach to optimization of patient outcome with drugs, such as betablockers and lipid-lowering medications (statins), is an evolving field, and recent developments are discussed in this article.
Mittnacht
Alexander Jc
AJ
Department of Anesthesiology, Mount Sinai Medical Center, New York, NY 10029, USA. alexander.mittnacht@msnyuhealth.org
Fanshawe
Michael
M
Konstadt
Steven
S
D000758:Anesthesia; D001022:Aortic Valve Insufficiency / Q000150:complications; D001024:Aortic Valve Stenosis / Q000150:complications; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications; D006349:Heart Valve Diseases / Q000150:complications*; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000150:complications; D008946:Mitral Valve Stenosis / Q000150:complications; D011182:Postoperative Care; D018570:Risk Assessment; D013514:Surgical Procedures, Operative